These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
674 related articles for article (PubMed ID: 30683887)
1. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Tyers M; Wright GD Nat Rev Microbiol; 2019 Mar; 17(3):141-155. PubMed ID: 30683887 [TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction. Coates ARM; Hu Y; Holt J; Yeh P Expert Rev Anti Infect Ther; 2020 Jan; 18(1):5-15. PubMed ID: 31847614 [No Abstract] [Full Text] [Related]
5. Combination therapy: the propitious rationale for drug development. Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510 [TBL] [Abstract][Full Text] [Related]
6. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Medina E; Pieper DH Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189 [TBL] [Abstract][Full Text] [Related]
7. The global need for effective antibiotics-moving towards concerted action. Cars O; Hedin A; Heddini A Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235 [TBL] [Abstract][Full Text] [Related]
8. Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance. Rex JH; Talbot GH; Goldberger MJ; Eisenstein BI; Echols RM; Tomayko JF; Dudley MN; Dane A Clin Infect Dis; 2017 Jul; 65(1):141-146. PubMed ID: 29017263 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens. Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767 [TBL] [Abstract][Full Text] [Related]
10. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?]. Ozseven AG; Sesli Çetin E; Ozseven L Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653 [TBL] [Abstract][Full Text] [Related]
11. Introduction into antibiotic combination treatment. Ellorhaoui M Ther Hung; 1978; 26(1):3-11. PubMed ID: 663873 [No Abstract] [Full Text] [Related]
12. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics. Konreddy AK; Rani GU; Lee K; Choi Y Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648 [TBL] [Abstract][Full Text] [Related]
13. [The use of antibiotic combinations]. Solberg CO Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1405-7. PubMed ID: 4751617 [No Abstract] [Full Text] [Related]
14. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522 [TBL] [Abstract][Full Text] [Related]
15. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials. O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605 [TBL] [Abstract][Full Text] [Related]
16. Current usage of antimicrobial combinations in pediatrics. Klein JO Pediatr Clin North Am; 1974 May; 21(2):443-56. PubMed ID: 4600414 [No Abstract] [Full Text] [Related]
17. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance. Viganor L; Howe O; McCarron P; McCann M; Devereux M Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043 [TBL] [Abstract][Full Text] [Related]
18. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era. Wang CH; Hsieh YH; Powers ZM; Kao CY Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic combinations. Allan JD Med Clin North Am; 1987 Nov; 71(6):1079-91. PubMed ID: 3320612 [TBL] [Abstract][Full Text] [Related]
20. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review. Annunziato G Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]